Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.10.6069

Comparative Serum Proteomic Analysis of Serum Diagnosis Proteins of Colorectal Cancer Based on Magnetic Bead Separation and MALDI-TOF Mass Spectrometry  

Deng, Bao-Guo (Department of Microbiology, Xinxiang Medical University)
Yao, Jin-Hua (Paediatrics Intensive Care Unit, the First Affiliated Hospital of Xinxiang Medical University)
Liu, Qing-Yin (The Clinical Laboratory, No.150 Central Hospital of PLA)
Feng, Xian-Jun (Department of Respiratory Medicine, the First Affiliated Hospital of Xinxiang Medical University)
Liu, Dong (Department of Dermatology, the First Affiliated Hospital of Xinxiang Medical University)
Zhao, Li (Paediatrics Intensive Care Unit, the First Affiliated Hospital of Xinxiang Medical University)
Tu, Bin (Import-Export Inspection and Quarantine Bureau of Luoyang)
Yang, Fan (Department of Microbiology, Xinxiang Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.10, 2013 , pp. 6069-6075 More about this Journal
Abstract
Background: At present, the diagnosis of colorectal cancer (CRC) requires a colorectal biopsy which is an invasive procedure. We undertook this pilot study to develop an alternative method and potential new biomarkers for diagnosis, and validated a set of well-integrated tools called ClinProt to investigate the serum peptidome in CRC patients. Methods: Fasting blood samples from 67 patients diagnosed with CRC by histological diagnosis, 55 patients diagnosed with colorectal adenoma by biopsy, and 65 healthy volunteers were collected. Division was into a model construction group and an external validation group randomly. The present work focused on serum proteomic analysis of model construction group by ClinProt Kit combined with mass spectrometry. This approach allowed construction of a peptide pattern able to differentiate the studied populations. An external validation group was used to verify the diagnostic capability of the peptidome pattern blindly. An immunoassay method was used to determine serum CEA of CRC and controls. Results: The results showed 59 differential peptide peaks in CRC, colorectal adenoma and health volunteers. A genetic algorithm was used to set up the classification models. Four of the identified peaks at m/z 797, 810, 4078 and 5343 were used to construct peptidome patterns, achieving an accuracy of 100% (> CEA, P<0.05). Furthermore, the peptidome patterns could differentiate the validation group with high accuracy close to 100%. Conclusions: Our results showed that proteomic analysis of serum with MALDI-TOF MS is a fast and reproducible approach, which may provide a novel approach to screening for CRC.
Keywords
peptidome patterns; colorectal cancer; diagnosis; magnetic beads; MALDI-TOF mass spectrometry;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cadeco S, Williamson AJ, Whetton AD (2012). The use of proteomics for systematic analysis of normal and transformed hematopoietic stem cells. Curr Pharm Des, 18, 1730-50.   DOI
2 Alagaratnam S, Mertens BJ, Dalebout JC, et al (2008). Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics, 8, 1552-63.   DOI   ScienceOn
3 Baumann S, Ceglarek U, Fiedler GM, et al (2005). Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem, 51, 973-80.   DOI   ScienceOn
4 Boja ES, Rodriguez H (2012). Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics, 12, 1093-110.   DOI   ScienceOn
5 Chinello C, Gianazza E, Zoppis I, et al (2010). Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. Urology, 75, 842-47.   DOI   ScienceOn
6 Cho WC (2007). Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer, 6, 25.   DOI   ScienceOn
7 Fan NJ, Gao CF, Wang XL (2011). Identification of regional lymph node involvement of colorectal cancer by serum SELDI proteomic patterns. Gastroenterol Res Pract, 2011, 784967.
8 Garay JP, Gray JW (2012). Omics and therapy - a basis for precision medicine. Mol Oncol, 6, 128-39.   DOI   ScienceOn
9 Fan NJ, Gao CF, Zhao G, Wang XL, Qiao L (2012). Serum peptidome patterns for early screening of esophageal squamous cell carcinoma. Biotechnol Appl Biochem, 59, 276-82.   DOI   ScienceOn
10 Fan NJ, Gao CF, Zhao G, Wang XL, Liu QY (2012).Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis. Diagn Pathol, 7, 45.   DOI
11 Gemoll T, Roblick UJ, Auer G, Jornvall H, Habermann JK (2010).SELDI-TOF serum proteomics and colorectal cancer: a current overview. Arch Physiol Biochem, 116, 188-96.   DOI   ScienceOn
12 Heckman-Stoddard BM (2012). Oncology biomarkers: discovery, validation, and clinical use. Semin Oncol Nurs, 28, 93-8.   DOI   ScienceOn
13 Huang YJ, Xuan C, Zhang BB, et al (2009). SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J Exp Clin Cancer Res, 28, 85.   DOI   ScienceOn
14 Hudler P, Gorsic M, Komel R (2010). Proteomic strategies and challenges in tumor metastasis research. Clin Exp Metastasis, 27, 441-51.   DOI
15 Issaq HJ, Xiao Z, Veenstra TD (2007): Serum and plasma proteomics. Chem Rev, 107, 3601-20.   DOI   ScienceOn
16 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
17 Compton CC, Greene FL (2004). The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin, 54, 295-308.   DOI   ScienceOn
18 Dai Y, Hu C, Wang L, et al (2010). Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. Scand J Rheumatol, 39, 240-6.   DOI   ScienceOn
19 Cho WC (2007). Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer, 6, 1.
20 Ciccolallo L, Capocaccia R, Coleman MP, et al (2005). Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut, 54, 268-73.   DOI   ScienceOn
21 Du J, Yang S, Lin X, et al (2010). Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer. Diagn Pathol, 5, 60.   DOI   ScienceOn
22 Edwards BK, Ward E, Kohler BA, et al (2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 116, 544-73.   DOI   ScienceOn
23 Engwegen JY, Depla AC, Smits ME, et al (2008). Detection of colorectal cancer by serum and tissue protein profiling: a prospective study in a population at risk. Biomark Insights, 3, 375-85.
24 Fan NJ, Gao CF, Wang CS, et al (2012). Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach. Can J Gastroentero, 26, 41-7.
25 Pang J, Liu WP, Liu XP, et al (2010).Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. J Proteome Res, 9, 216-26.   DOI   ScienceOn
26 Pan C, He N, Zhao M, et al (2011). Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival. Med Oncol, 28, 1349-55.   DOI   ScienceOn
27 Ketterlinus R, Hsieh SY, Teng SH, Lee H, Pusch W (2005). Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. Biotechniques, Suppl, 37-40.
28 Liu LH, Shan BE, Tian ZQ, et al (2010). Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem Lab Med, 48, 855-61.
29 Shin S, Cazares L, Schneider H, et al (2007). Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg, 204, 1065-71; discussion 1071-3.   DOI   ScienceOn
30 Smith RA, Cokkinides V, Brooks D, et al (2011). Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin , 61, 8-30.   DOI
31 Wang Q, Shen J, Li ZF, et al (2009).Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer. BMC Cancer, 9, 287.   DOI   ScienceOn
32 West-Norager M, Kelstrup CD, Schou C, et al (2007). Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci, 847, 30-7.   DOI   ScienceOn
33 Fan NJ, Gao CF, Wang CS, et al (2012).Identification of the up-regulation of TP-alpha, collagen alpha-1 (VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method. J Proteomics, 75, 3977-86.   DOI   ScienceOn
34 Cheng AJ, Chen LC, Chien KY, et al (2005). Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem, 51, 2236-44.   DOI   ScienceOn
35 Jemal A, Siegel R, Xu J, Ward E (2010).Cancer statistics2010. CA Cancer J Clin, 60, 277-300.   DOI
36 Tolson JP, Flad T, Gnau V, et al (2006). Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics, 6, 697-708.   DOI   ScienceOn
37 Whiteaker JR, Zhao L, Zhang HY, et al (2007). Antibody-based enrichment of peptides on magnetic beads for massspectrometry-based quantification of serum biomarkers. Anal Biochem, 362, 44-54.   DOI   ScienceOn
38 Yao N, Chen H, Lin H, Deng C, Zhang X (2008). Enrichment of peptides in serum by C (8)-functionalized magnetic nanoparticles for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis. J Chromatogr A, 1185, 93-101.   DOI   ScienceOn
39 Zethelius B, Berglund L, Sundstrom J, et al (2008).Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med, 358, 2107-16.   DOI   ScienceOn